BTMD compared with DFTX: revenue, margins and what each company keeps, and the suppliers and customers both name

BTMDbiote Corp.

Mkt capRevenueRevenue

DFTXDefinium Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

BTMDbiote Corp.

DFTXDefinium Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

BTMDbiote Corp.

1.21▲+7.93%· post 1.10

Mkt cap$40.2MRevenue$44MQ2 FY26Revenue$192MFY25

DFTXDefinium Therapeutics, Inc.

32.70▼−2.11%· post 32.38

ClosedNov 4 '26

Mkt cap$4.4BRevenue—Revenue—

Compare

ClosedNov 4 '26

BTMDbiote Corp.

DFTXDefinium Therapeutics, Inc.

1.21▲+7.93%post 1.10

Price

32.70▼−2.11%post 32.38

$40.2M

Mkt cap

$4.4B

Q2 FY26$44M

Revenue

—

FY25$192M

Revenue

—

BTMD1.21▲+7.93%vsDFTX32.70▼−2.11%ClosedNov 4 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

BTMD: latest quarter is a loss; flow not drawable. DFTX: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

No disclosed counterparties: BTMD, DFTX.

Role chip = supplier or customerSource: SEC EDGAR

Price

rebased to 0%

BTMD, solidDFTX, dashed